PPD PPD, Inc. Stock Quote

PPD [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	225.71	EPS (ttm)	0.15	Insider Own	0.30%	Shs Outstand	348.58M	Perf Week	-0.86%
Market Cap	11.75B	Forward P/E	20.95	EPS next Y	1.66	Insider Trans	-98.35%	Shs Float	158.64M	Perf Month	0.09%
Income	53.80M	PEG	13.11	EPS next Q	0.31	Inst Own	77.10%	Short Float	2.70%	Perf Quarter	1.19%
Sales	4.36B	P/S	2.69	EPS this Y	-43.50%	Inst Trans	25.15%	Short Ratio	4.54	Perf Half Y	0.75%
Book/sh	-3.06	P/B	-	EPS next Y	17.16%	ROA	1.10%	Target Price	41.93	Perf Year	19.82%
Cash/sh	2.05	P/C	16.95	EPS next 5Y	17.22%	ROE	-3.40%	52W Range	10.61 - 38.76	Perf YTD	1.58%
Dividend	-	P/FCF	39.85	EPS past 5Y	-	ROI	14.10%	52W High	-10.32%	Beta	-
Dividend %	-	Quick Ratio	1.10	Sales past 5Y	-	Gross Margin	39.50%	52W Low	227.62%	ATR	1.46
Employees	23000	Current Ratio	1.10	Sales Q/Q	1.40%	Oper. Margin	8.50%	RSI (14)	45.63	Volatility	4.75% 3.75%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	-140.80%	Profit Margin	1.50%	Rel Volume	1.66	Prev Close	33.54
Shortable	Yes	LT Debt/Eq	-	Earnings	Feb 24 BMO	Payout	0.00%	Avg Volume	943.42K	Price	34.76
Recom	1.70	SMA20	-3.59%	SMA50	-1.66%	SMA200	5.92%	Volume	1,554,093	Change	3.64%

Mar-03-21

Initiated

Barclays

Overweight

$42

Oct-12-20

Initiated

Truist

Buy

Jun-04-20

Initiated

KeyBanc Capital Markets

Overweight

$35

Mar-23-20

Upgrade

Jefferies

Hold → Buy

$30.50 → $20

Mar-02-20

Initiated

William Blair

Outperform

Mar-02-20

Initiated

UBS

Buy

$34

Mar-02-20

Initiated

Robert W. Baird

Outperform

$35

Mar-02-20

Initiated

Morgan Stanley

Overweight

$34

Mar-02-20

Initiated

Mizuho

Buy

$32

Mar-02-20

Initiated

JP Morgan

Overweight

$35

Mar-02-20

Initiated

Jefferies

Hold

$30.50

Mar-02-20

Initiated

Goldman

Buy

$34

Mar-02-20

Initiated

Evercore ISI

Outperform

$33

Mar-02-20

Initiated

Deutsche Bank

Buy

$33

Mar-02-20

Initiated

Credit Suisse

Outperform

$32

Mar-02-20

Initiated

Citigroup

Buy

$34

Mar-02-20

Initiated

BofA/Merrill

Buy

$33

Mar-02-20

Initiated

Barclays

Overweight

$33

Mar-03-21 10:02AM	Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2021 Benzinga
Feb-26-21 10:00AM	PPD Lights Up Headquarters Downtown for 2021 Rare Disease Day Business Wire
08:30AM	Stock Chart Analysis: Saucer With Handle Base Less Common, But Packs A Punch Investor's Business Daily
Feb-24-21 05:31PM	PPD, Inc. (PPD) Q4 2020 Earnings Call Transcript Motley Fool
07:00AM	PPD to Present at Barclays Global Healthcare Conference Business Wire
Feb-23-21 04:05PM	PPD Reports Fourth Quarter and Full Year 2020 Results Business Wire
Feb-18-21 09:00AM	PPD Awarded US Army Study to Help Develop Post-Traumatic Stress Disorder Drugs Business Wire
Feb-17-21 10:00AM	PPD Honored for Employee Development Programs that Deliver Results for Customers Business Wire
Feb-09-21 06:30AM	AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for COVID-19 Gastrointestinal Infections GlobeNewswire
Feb-03-21 05:10PM	PPD Announces Fourth Quarter and Full-Year 2020 Earnings Conference Call Business Wire
Jan-04-21 09:00AM	PPD to Present at the 39th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-28-20 06:22AM	Have Insiders Been Buying PPD, Inc. (NASDAQ:PPD) Shares This Year? Simply Wall St.
Dec-23-20 12:20PM	Why PPD, Inc. (PPD) Might be Well Poised for a Surge Zacks
Dec-21-20 05:25PM	Is PPD A Good Stock To Buy According To Hedge Funds? Insider Monkey
Dec-07-20 09:00AM	PPD Recognized as a Best Place to Work in Greater China Business Wire
Nov-02-20 10:15AM	PPD Named Clinical Research Company of the Year Business Wire
Oct-29-20 10:36AM	PPD, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now Simply Wall St.
Oct-28-20 07:00AM	PPD Inc to Host Earnings Call ACCESSWIRE
Oct-27-20 04:05PM	PPD Reports Third Quarter and Year to Date 2020 Results Business Wire
Oct-26-20 08:00AM	Accelerated Enrollment Solutions Wins SCRS Site Tank Award Business Wire
Oct-13-20 09:00AM	PPD to Open Multipurpose Clinical Research Laboratory in Suzhou, China Business Wire
Oct-12-20 04:05PM	PPD Announces Third Quarter 2020 Earnings Conference Call Business Wire
01:39PM	Are Institutions Heavily Invested In PPD, Inc.'s (NASDAQ:PPD) Shares? Simply Wall St.
Oct-06-20 09:00AM	PPD Recognized at Vaccine Industry Excellence Awards Business Wire
Sep-30-20 09:00AM	PPD Achieves ISO/IEC 27001:2013 Certification for Information Security Management Business Wire +5.23%
Sep-28-20 01:24PM	Do Hedge Funds Like PPD, Inc. (PPD)? Insider Monkey
Sep-17-20 12:00PM	PPD Named a Top 50 Employer in Bulgaria Business Wire
Sep-16-20 10:32PM	PPD Announces Pricing of Secondary Offering of Shares of Common Stock Business Wire
Sep-14-20 04:06PM	PPD Announces Secondary Offering of Shares of Common Stock Business Wire
04:05PM	PPD Updates Third Quarter 2020 Financial Guidance Business Wire
Sep-09-20 09:00AM	PPD Recognized for Excellence in Clinical Research Training Business Wire
Sep-03-20 09:00AM	PPD and Lupus Therapeutics Collaborate to Support Lupus Clinical Research Business Wire
Aug-24-20 11:05AM	Forbes Names PPD One of North Carolinas Best Employers Business Wire
Aug-20-20 07:55AM	Science 37® Raises $40 Million to Extend Its Leadership in the Decentralized Clinical Trial Market PR Newswire
Aug-14-20 09:00AM	Two PPD Senior Leaders Recognized for Life Sciences Industry Leadership Business Wire
Aug-12-20 03:11PM	Estimating The Intrinsic Value Of PPD, Inc. (NASDAQ:PPD) Simply Wall St.
Aug-04-20 04:05PM	PPD Reports Second Quarter and Year to Date 2020 Results Business Wire
Aug-03-20 09:00AM	PPD Signs New Service Agreement with Pfizer Business Wire +6.40%
Jul-21-20 04:05PM	PPD Announces Second Quarter 2020 Earnings Release Date and Conference Call Business Wire
Jul-17-20 12:00PM	7 New Stocks to Buy for 2021 and Beyond InvestorPlace +5.28%
Jun-25-20 09:00AM	PPD Expands Laboratory Test Portfolio for COVID-19 Therapy and Vaccine Development Programs Business Wire
Jun-04-20 09:42AM	Benzinga's Top Upgrades, Downgrades For June 4, 2020 Benzinga
May-21-20 05:20PM	PPD, Inc. Announces Pricing and Upsizing of Senior Notes Offering Business Wire
07:10AM	PPD, Inc. Announces Offering of Senior Notes Business Wire
May-14-20 09:00AM	PPD Honored for Quality and Capabilities in CRO Leadership Awards Business Wire
May-06-20 04:01PM	PPD Reports First Quarter 2020 Results Business Wire
09:42AM	Have Insiders Been Buying PPD, Inc. (NASDAQ:PPD) Shares This Year? Simply Wall St.
May-01-20 04:55PM	Vanguard Health Care Fund's Top 5 1st-Quarter Trades GuruFocus.com
Apr-29-20 09:05AM	PPD Extends Digital Clinical Trial Capabilities to Support Biopharma Companies Research Continuity and Patient Safety during COVID-19 Pandemic Business Wire
Apr-23-20 09:00AM	PPD Announces First Quarter 2020 Earnings Release Date and Conference Call Business Wire
Apr-16-20 09:00AM	Accelerated Enrollment Solutions Launches Patient-Transfer Program to Support Clinical Trial Continuity for Biopharma Companies During COVID-19 Pandemic Business Wire
Apr-02-20 09:00AM	Accelerated Enrollment Solutions and Science 37 Collaborate to Provide Virtual Trial Access to Patients Globally Business Wire
Mar-17-20 09:00AM	PPD Named CIO 100 Award Winner for Clinical Research Data-Visualization Tool Business Wire
Mar-10-20 04:01PM	PPD Announces Cancellation of Fireside Chat and Webcast at the Barclays Global Healthcare Conference 2020 Business Wire
Mar-05-20 04:01PM	PPD to Participate in Barclays Global Healthcare Conference Business Wire
Mar-04-20 04:01PM	PPD Reports Fourth Quarter and Full Year 2019 Results Business Wire
Mar-03-20 10:03AM	Goldman Sachs: 3 IPO Stocks to Snap Up Now TipRanks
Mar-02-20 02:31PM	Credit Markets Ignore Equity Rally With Fear Gauges Flashing Red Bloomberg
Feb-25-20 09:15AM	PPD Recognized for Leadership in Employee Training and Development Business Wire -5.14%
Feb-20-20 09:00AM	PPD Announces Fourth Quarter and Full Year 2019 Earnings Release Date and Conference Call Business Wire
Feb-17-20 10:36AM	Weekly CEO Buys Highlight GuruFocus.com
Feb-16-20 04:07PM	Top Insider Buys Highlight for the Week of Feb. 14 GuruFocus.com
Feb-07-20 04:17PM	Casper Sleep Slips Below IPO Price on Second Day as Public Firm Bloomberg
Feb-06-20 04:33PM	Casper Ends Public Debut Worth Less Than Half Private Valuation Bloomberg
11:15AM	Drug research company PPD' shares soar 14% in trading debut MarketWatch
Feb-05-20 07:44PM	PPD Inc. Raises $1.62 Billion in 2020s Biggest U.S. IPO Bloomberg
06:08PM	PPD prices IPO at high end of range MarketWatch
06:00PM	Casper to Price IPO Shares at $12, Bottom of Lower Range Bloomberg
Feb-01-20 02:34PM	IPO market braces for first billion-dollar deals of 2020and Casper wont be one of them MarketWatch
Jan-27-20 07:31AM	PPD sets IPO terms, to be valued at $9.2 billion MarketWatch

PPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. PPD, Inc. was founded in 1985 and is headquartered in Wilmington, North Carolina.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Donovan Glen	Chief Accounting Officer	Mar 03	Option Exercise	10.59	16,347	173,115	19,347	Mar 05 05:02 PM
Donovan Glen	Chief Accounting Officer	Mar 03	Sale	35.62	16,347	582,280	3,000	Mar 05 05:02 PM
Johnston David Michael	See Remarks	Mar 02	Option Exercise	10.59	21,597	228,712	57,004	Mar 03 04:17 PM
Garrow Ronald E	See Remarks	Mar 02	Option Exercise	17.55	69,401	1,217,868	69,401	Mar 04 05:01 PM
Garrow Ronald E	See Remarks	Mar 02	Sale	36.38	69,401	2,524,808	0	Mar 04 05:01 PM
Johnston David Michael	See Remarks	Mar 02	Sale	36.29	21,597	783,755	35,407	Mar 03 04:17 PM
Johnston David Michael	See Remarks	Mar 01	Option Exercise	10.59	21,597	228,712	74,704	Mar 03 04:17 PM
Johnston David Michael	See Remarks	Mar 01	Sale	35.43	39,297	1,392,293	35,407	Mar 03 04:17 PM
SIMMONS DAVID S	Chief Executive Officer	Feb 12	Sale	38.01	77,065	2,929,241	693,695	Feb 16 05:00 PM
SIMMONS DAVID S	Chief Executive Officer	Nov 10	Option Exercise	10.59	30,000	317,700	987,759	Nov 12 04:02 PM
SIMMONS DAVID S	Chief Executive Officer	Oct 30	Option Exercise	10.59	50,000	529,500	957,759	Nov 03 04:43 PM
HARTMAN JUDD	See Remarks	Sep 29	Sale	34.60	30,000	1,038,000	64,166	Oct 01 05:00 PM
Kaucic Karen	See Remarks	Sep 29	Sale	34.80	20,574	715,975	8,392	Oct 01 05:00 PM
Pellegrino Jill	SVP & General Manager of AES	Sep 28	Option Exercise	15.05	2,837	42,697	5,495	Sep 30 05:00 PM
Pellegrino Jill	SVP & General Manager of AES	Sep 28	Sale	34.40	5,495	189,028	0	Sep 30 05:00 PM
Donovan Glen	Chief Accounting Officer	Sep 22	Sale	34.76	2,833	98,475	3,000	Sep 24 05:00 PM
Carlyle Group Management L.L.C	10% Owner	Sep 21	Sale	31.28	10,732,261	335,731,955	55,722,733	Sep 22 04:15 PM
Johnston David Michael	See Remarks	Sep 21	Sale	33.11	40,000	1,324,400	53,107	Sep 23 05:01 PM
H&F Corporate Investors VIII,	10% Owner	Sep 21	Sale	31.28	24,702,175	772,745,789	157,138	Sep 23 04:48 PM
H&F Corporate Investors VII, L	10% Owner	Sep 21	Sale	31.28	24,702,175	772,745,789	157,138	Sep 23 04:47 PM
Hill Colin	Director	Sep 21	Sale	31.28	1,722	53,868	14,166	Sep 23 04:44 PM
Garrow Ronald E	See Remarks	Sep 18	Option Exercise	14.55	9,500	138,225	9,500	Sep 22 05:01 PM
Garrow Ronald E	See Remarks	Sep 18	Sale	34.12	9,500	324,140	0	Sep 22 05:01 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience